Please Wait
Applying Filters...

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Glycopath is utilizing a rapidly growing field of knowledge and sophisticated instrumentation to create innovative solutions to roadblocks in biomarker discovery and clinical assay development. GlycoPath Inc. is a developer of GlycoTyper-based bioanalytical assays using the Company's proprietary platform technology, developed at the Medical University of South Carolina and licensed from the MUSC Foundation for Research Develop...
Glycopath is utilizing a rapidly growing field of knowledge and sophisticated instrumentation to create innovative solutions to roadblocks in biomarker discovery and clinical assay development. GlycoPath Inc. is a developer of GlycoTyper-based bioanalytical assays using the Company's proprietary platform technology, developed at the Medical University of South Carolina and licensed from the MUSC Foundation for Research Development.

List your booth number for exhibitions, ask us